Literature DB >> 3539644

The response of patients with organic hypothalamic-pituitary disease to pulsatile gonadotropin-releasing hormone therapy.

D V Morris, N A Abdulwahid, A Armar, H S Jacobs.   

Abstract

Treatment with pulsatile gonadotropin-releasing hormone (GnRH) therapy has been attempted in 13 women and 5 men with hypogonadotropic hypogonadism caused by structural lesions of the hypothalamic-pituitary axis. Ten patients responded to treatment with induction of ovulation or spermatogenesis. Of these subjects, seven had primary suprasellar lesions, and one had an apparently empty pituitary fossa on reconstructive computerized tomographic scanning. The eight patients who failed to respond to treatment all had extensive intrafossa damage, as a result of either surgery, irradiation, or infarction. Pulsatile GnRH therapy is not effective in patients with extensive intrafossa lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3539644     DOI: 10.1016/s0015-0282(16)49935-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  Update on pulsatile luteinizing hormone-releasing hormone therapy in males with idiopathic hypogonadotropic hypogonadism and delayed puberty.

Authors:  M Giusti; P Cavagnaro
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

Review 2.  Aetiology, diagnosis, and management of hypopituitarism in adult life.

Authors:  V K B Prabhakar; S M Shalet
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

3.  One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation.

Authors:  R Homburg; A Eshel; N A Armar; M Tucker; P W Mason; J Adams; J Kilborn; I A Sutherland; H S Jacobs
Journal:  BMJ       Date:  1989-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.